ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Omron Corp (PK)

Omron Corp (PK) (OMRNF)

32.05
0.00
(0.00%)
Cerrado 05 Enero 3:00PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
32.05
Postura de Compra
30.70
Postura de Venta
36.86
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
30.72 Rango de 52 semanas 47.46
Capitalización de Mercado [m]
Precio Anterior
32.05
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
452
Acciones en circulación
197,427,388
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.78
Beneficio por acción (BPA)
41.05
turnover
821.35B
Beneficio neto
8.11B

Acerca de Omron Corp (PK)

Sector
Semiconductor,related Device
Industria
Electronics Diversified
Sitio web
Sede
Kyoto, Kyoto, Jpn
Fundado
1984
Omron Corp (PK) is listed in the Semiconductor,related Device sector of the OTCMarkets with ticker OMRNF. The last closing price for Omron (PK) was US$32.05. Over the last year, Omron (PK) shares have traded in a share price range of US$ 30.72 to US$ 47.46.

Omron (PK) currently has 197,427,388 shares in issue. The market capitalisation of Omron (PK) is US$6.33 billion. Omron (PK) has a price to earnings ratio (PE ratio) of 0.78.

OMRNF Últimas noticias

AT&T and NEC Jointly Implement Companywide VoIP Solution for OMRON Corporation

AT&T and NEC Jointly Implement Companywide VoIP Solution for OMRON Corporation Over 10,000 telephones installed at 81 business locations in Japan TOKYO, April 22 /PRNewswire/ -- AT&T and NEC...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
4-2.8228-8.0945608038434.872834.872831.9544033.48496309CS
121.033.3204384268231.0234.872830.7245232.87351614CS
26-1.69-5.0088915234133.7441.330.7228533.27021476CS
52-12-27.241770715144.0547.4630.72116938.65050111CS
156-62.615-66.143770136894.66594.66530.72101748.68821388CS
260-26.85-45.585738539958.9103.997930.7299258.01286355CS

OMRNF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Omron (PK)?
El precio actual de las acciones de Omron (PK) es US$ 32.05
¿Cuántas acciones de Omron (PK) están en circulación?
Omron (PK) tiene 197,427,388 acciones en circulación
¿Cuál es la capitalización de mercado de Omron (PK)?
La capitalización de mercado de Omron (PK) es USD 6.33B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Omron (PK)?
Omron (PK) ha negociado en un rango de US$ 30.72 a US$ 47.46 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Omron (PK)?
El ratio precio/beneficio de Omron (PK) es 0.78
¿Cuál es el ratio de efectivo a ventas de Omron (PK)?
El ratio de efectivo a ventas de Omron (PK) es 0.01
¿Cuál es la moneda de reporte de Omron (PK)?
Omron (PK) presenta sus resultados financieros en JPY
¿Cuál es el último ingresos anual de Omron (PK)?
El último ingresos anual de Omron (PK) es JPY 821.35B
¿Cuál es el último beneficio anual de Omron (PK)?
El último beneficio anual de Omron (PK) es JPY 8.11B
¿Cuál es la dirección registrada de Omron (PK)?
La dirección registrada de Omron (PK) es 801 NINAMIFUDODOU-MACHI, SHIOKOUJIDORI HORIKAWA, HIGAHIIRU, KYOTO, KYOTO, 600-8234
¿Cuál es la dirección del sitio web de Omron (PK)?
La dirección del sitio web de Omron (PK) es www.omron.co.jp
¿En qué sector industrial opera Omron (PK)?
Omron (PK) opera en el sector ELECTRONICS DIVERSIFIED

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EGIOQEdgio Inc (CE)
US$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
US$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
US$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
US$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
US$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
US$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
US$ 0.00125
(-10.71%)
169.44M
igotthemojo igotthemojo 22 minutos hace
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 25 minutos hace
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 32 minutos hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 44 minutos hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 46 minutos hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 48 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 49 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 49 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 51 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 52 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 54 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 54 minutos hace
Not good, thanks for sharing.
sand sand 1 hora hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hora hace
Moving hard soon 
EFSH
mining101 mining101 1 hora hace
Superb
MEGL
benz280c benz280c 1 hora hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 1 hora hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 1 hora hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hora hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hora hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hora hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 2 horas hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 2 horas hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL